Navigation Links
Mayo Clinic researchers discover cancer cells may move via wave stimulation

Mayo Clinic researchers have uncovered a new cellular secret that may explain how certain cancers move and spread -- a feature of cancers that makes treatment especially difficult. If the mechanism that drives cancer movement -- also called metastasis -- can be understood well enough to manipulate it, new and better treatments can be developed for patients with metastatic cancers.

Significance of the Mayo Clinic Research

The Mayo researchers focused on odd protrusions observable by microscope on the surface of certain cancer cells: circular waves. Until now, no one has fully understood the function of these waves. The Mayo findings in the current edition of Cancer Research http://cancerres.aacrjournals.org/current.shtml are the first to show one role the waves play. They selectively round up activated growth-promoting proteins from the cell surface and take them to the interior of the cell. Under normal conditions, this process would help terminate signals from these growth-promoting proteins. However, in cancer cells it appears that either these waves may not function properly, or that the internalized proteins may remain active longer, which allows them to "instruct" a cell to acquire cancerous traits such as excessive growth and invasive movement that constitute metastasis. These waves are important for helping to keep these cancer-growth commands at bay.

Studying human pancreatic tumor cells, the Mayo researchers found that the waves store up to half the activated Epidermal Growth Factor Receptors (EGFR) from the surface of the cell and take this cache to the interior of the cells. This is important for understanding cancer because aberrant activation of EGFR can promote the excessive growth typical of cancers.

"These findings have broad implications toward the general understanding of how specific processes in the wave may affect such things as cell growth, cell
'"/>

Source:Mayo Clinic


Page: 1 2 3

Related biology news :

1. Mayo Clinic Researchers Create Obedient Virus; First Step To Use Measles Virus Against Cancer
2. Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show Its Snot
3. Clinical trial to test stem cell approach for children with brain injury
4. Mayo Clinic collaboration discovers protein amplifies DNA injury signals
5. Mayo Clinic researchers challenge sepsis theory
6. Mayo Clinic study finds two genes predict outcome for breast cancer patients
7. Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
8. Mayo Clinic collaboration mining of ancient herbal text leads to potential new anti-bacterial drug
9. Mayo Clinic study suggests that a central nervous system viral infection can lead to memory deficits
10. Mayo Clinic: Gene expression profiling not quite perfected in predicting lung cancer prognosis
11. NYU researchers simulate molecular biological clock

Post Your Comments:
(Date:11/24/2009)...or thousands of years it has been prescribed by tr...lments from headaches and stomach pain to fever an...ewcastle University have been able to scientifical...crenata otherwise known as Brazilian mint. , Te...e team led by researcher Graciela Rocha was able t...
(Date:11/24/2009)...he atomic-level action of a remarkable class of ri...earchers with the Lawrence Berkeley National Labor...ein crystallography beamline at the Advanced Light...oles in gene expression and replication, and are v...ell as infectious agents, such as the human papill...
(Date:11/24/2009)...ambridge, Md. (November 24, 2009) New research on... river ecosystems reveals predictable temporal pat...communities as markers for monitoring climate chan... week in the Proceedings of the National Academy ...ommunities in the six rivers shifted synchronously...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 1iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 2Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader 13762 1Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader 13762 2Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader 13762 3Blood Thinner May Prevent Chemo Related Clots 55837 1Blood Thinner May Prevent Chemo Related Clots 55837 2
...at Rensselaer Polytechnic Institute have discovere...o live. In two recently published papers, the scie...m behind the pathogen that causes cholera. The wor...hogen, while also offering insight into how cells ...ms required to sustain life. , As a single-cell or...
...5th issue of G&D, Dr. Michael Carey (UCLA,s Jo...lend new insight into the mechanism of epigenetic ...sizes that "The study provides a new direction to ...enomena that play a significant role in stem cell ...ach other to turn genes off. " , Although both...
...ew imaging technology, researchers are getting a b...w insects, which have a respiratory system built t...vive for days without it. , The insect respiratory...taking in air as they release carbon dioxide, acco...iversity in Berlin, Germany. This allows them to k...
Other Biology News:Cholera pathogen reveals how bacteria generate energy to live 2Cholera pathogen reveals how bacteria generate energy to live 3Breathing easy: When it comes to oxygen, a bug's life is full of it 2Breathing easy: When it comes to oxygen, a bug's life is full of it 3Breathing easy: When it comes to oxygen, a bug's life is full of it 4
(Date:11/24/2009)... The New York investment b...d (ASX:NEU) has agreed an AU$6.7 mil convertible n...vestor. The private placement was arranged by KTA ...advisor. , New York (PRWE...nvestment bank KTA Capital, LLC ("KTA Capital...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-Fir...nnouncedthatithasreceivednoticefrom,theNasdaqStock...uspendedasofNovember30,2009andaForm25-NSEwillbefil...lremovedeCODE,scommonstock,fromlistingonNasdaq,unl...ficationsPanel.Thecompanyhasfiledsuchanappeal,whic...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-Fir...nnouncedtheapprovalofallofits,"firstday"motionsbyt..."BankruptcyCourt").deCODElastweekfiledavoluntarype...kruptcyCodewiththe,BankruptcyCourt. , Theorde...nue,tooperateitsbusinessduringtheChapter11proceedi...
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiB...stration(SFDA)hasapprovedthe,investigationalnewdru...,aninnovativeinsulinformulationtotreatdiabetes.Thi...clinicalstudy. , Diabetesisadisordercharacter...icationsofdiabetesoftenresultinseveremicro-and,mac...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
...r KOS-1584, HAYWARD, Calif., Oct. 25 Kosan Biosc...ed that Roche and Kosan are,concluding their epoth...ion. The collaborative research, development and,c...er 2002 will terminate,after a transition period, ...hts to its epothilone program and have full contro...
...RTC International Conference, SAN DIEGO, Oct. 25 ...opharmaceutical research and development company,f...idates for the treatment,of cancer and infectious ...,results demonstrating that ANX-514, the company,s...ersensitivity reactions without impacting,pharmaco...
...Inc. (OTC Bulletin Board: NILT.OB) will present at...ence at 10:30 AM EST on Wednesday, November 7th at... Chief Executive Officer of Nile will provide an,o...lopment programs,including data from Nile,s recent...CD-NP, a novel chimeric peptide for the treatment ...
Other Biology Technology:Kosan to Reacquire Epothilone Program From Roche 2Kosan to Reacquire Epothilone Program From Roche 3Kosan to Reacquire Epothilone Program From Roche 4ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 2ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 3ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 4ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests 5Nile Therapeutics to Present at the Rodman & Renshaw 9th Annual Healthcare Conference 2
...ntended for users requiring mass detection but not... TOF Mass spectrometer is ideally suited for high ...ance mass analysis. Typical applications include ...tion, micro-satellite DNA characterization and pol...
RAOSMC (R354-05) from European Collection of Cell Cultures (ECACC)
RDF (R106-05) from European Collection of Cell Cultures (ECACC)
...he miVac DNA is an ideal small concentrator for th...l concentrator capable of removing water and organ...ding tubes, microplates, vials and round bottom fl... for the busy lab. ,The built-in special runs...
Biology Products: